These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24647444)

  • 1. NTRK1 fusion in glioblastoma multiforme.
    Kim J; Lee Y; Cho HJ; Lee YE; An J; Cho GH; Ko YH; Joo KM; Nam DH
    PLoS One; 2014; 9(3):e91940. PubMed ID: 24647444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.
    Park DY; Choi C; Shin E; Lee JH; Kwon CH; Jo HJ; Kim HR; Kim HS; Oh N; Lee JS; Park OK; Park E; Park J; Shin JY; Kim JI; Seo JS; Park HD; Park J
    Oncotarget; 2016 Feb; 7(7):8399-412. PubMed ID: 26716414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.
    Cook PJ; Thomas R; Kannan R; de Leon ES; Drilon A; Rosenblum MK; Scaltriti M; Benezra R; Ventura A
    Nat Commun; 2017 Jul; 8():15987. PubMed ID: 28695888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foretinib Overcomes Entrectinib Resistance Associated with the
    Nishiyama A; Yamada T; Kita K; Wang R; Arai S; Fukuda K; Tanimoto A; Takeuchi S; Tange S; Tajima A; Furuya N; Kinoshita T; Yano S
    Clin Cancer Res; 2018 May; 24(10):2357-2369. PubMed ID: 29463555
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer.
    Xia H; Xue X; Ding H; Ou Q; Wu X; Nagasaka M; Shao YW; Hu X; Ou SI
    Clin Lung Cancer; 2020 May; 21(3):247-254. PubMed ID: 31761448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade glioneuronal tumor with an ARHGEF2-NTRK1 fusion gene.
    Kurozumi K; Nakano Y; Ishida J; Tanaka T; Doi M; Hirato J; Yoshida A; Washio K; Shimada A; Kohno T; Ichimura K; Yanai H; Date I
    Brain Tumor Pathol; 2019 Jul; 36(3):121-128. PubMed ID: 31011918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.
    Komuro A; Raja E; Iwata C; Soda M; Isogaya K; Yuki K; Ino Y; Morikawa M; Todo T; Aburatani H; Suzuki H; Ranjit M; Natsume A; Mukasa A; Saito N; Okada H; Mano H; Miyazono K; Koinuma D
    Int J Cancer; 2018 Apr; 142(8):1627-1639. PubMed ID: 29193056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma.
    Créancier L; Vandenberghe I; Gomes B; Dejean C; Blanchet JC; Meilleroux J; Guimbaud R; Selves J; Kruczynski A
    Cancer Lett; 2015 Aug; 365(1):107-11. PubMed ID: 26001971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined c-Met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in Glioblastoma.
    Olmez I; Zhang Y; Manigat L; Benamar M; Brenneman B; Nakano I; Godlewski J; Bronisz A; Lee J; Abbas T; Abounader R; Purow B
    Cancer Res; 2018 Aug; 78(15):4360-4369. PubMed ID: 29844123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
    Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.
    Dai HP; Xue YQ; Zhou JW; Li AP; Wu YF; Pan JL; Wang Y; Zhang J
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1027-36. PubMed ID: 19760607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
    Oelmann E; Sreter L; Schuller I; Serve H; Koenigsmann M; Wiedenmann B; Oberberg D; Reufi B; Thiel E; Berdel WE
    Cancer Res; 1995 May; 55(10):2212-9. PubMed ID: 7538048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
    Greco A; Mariani C; Miranda C; Lupas A; Pagliardini S; Pomati M; Pierotti MA
    Mol Cell Biol; 1995 Nov; 15(11):6118-27. PubMed ID: 7565764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTRK1 and NTRK2 receptors facilitate follicle assembly and early follicular development in the mouse ovary.
    Kerr B; Garcia-Rudaz C; Dorfman M; Paredes A; Ojeda SR
    Reproduction; 2009 Jul; 138(1):131-40. PubMed ID: 19357131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.
    Parker BC; Annala MJ; Cogdell DE; Granberg KJ; Sun Y; Ji P; Li X; Gumin J; Zheng H; Hu L; Yli-Harja O; Haapasalo H; Visakorpi T; Liu X; Liu CG; Sawaya R; Fuller GN; Chen K; Lang FF; Nykter M; Zhang W
    J Clin Invest; 2013 Feb; 123(2):855-65. PubMed ID: 23298836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.
    Vaishnavi A; Capelletti M; Le AT; Kako S; Butaney M; Ercan D; Mahale S; Davies KD; Aisner DL; Pilling AB; Berge EM; Kim J; Sasaki H; Park S; Kryukov G; Garraway LA; Hammerman PS; Haas J; Andrews SW; Lipson D; Stephens PJ; Miller VA; Varella-Garcia M; Jänne PA; Doebele RC
    Nat Med; 2013 Nov; 19(11):1469-1472. PubMed ID: 24162815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy.
    Joshi AD; Loilome W; Siu IM; Tyler B; Gallia GL; Riggins GJ
    PLoS One; 2012; 7(10):e44372. PubMed ID: 23056179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma.
    Zeng AL; Yan W; Liu YW; Wang Z; Hu Q; Nie E; Zhou X; Li R; Wang XF; Jiang T; You YP
    Oncogene; 2017 Sep; 36(38):5369-5381. PubMed ID: 28504721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of NTRK1 mutations identified in melanoma.
    Miranda C; Mazzoni M; Sensi M; Pierotti MA; Greco A
    Genes Chromosomes Cancer; 2014 Oct; 53(10):875-80. PubMed ID: 24965840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21).
    Charest A; Lane K; McMahon K; Park J; Preisinger E; Conroy H; Housman D
    Genes Chromosomes Cancer; 2003 May; 37(1):58-71. PubMed ID: 12661006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.